Irisin and Visfatin Predicts Severity of Diabetic Nephropathy.

Mageswari, Ramalingam; Sridhar, M G; Nandeesha, H; Parameshwaran, Sreejith; Vinod, K V

Mageswari, Ramalingam; Sridhar, M G; Nandeesha, H; Parameshwaran, Sreejith; Vinod, K V.

Afiliação

Mageswari R; Department of Biochemistry, Medicine and Nephrology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, 605006 India.
Sridhar MG; Department of Biochemistry, Medicine and Nephrology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, 605006 India.
Nandeesha H; Department of Biochemistry, Medicine and Nephrology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, 605006 India.
Parameshwaran S; Department of Biochemistry, Medicine and Nephrology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, 605006 India.
Vinod KV; Department of Biochemistry, Medicine and Nephrology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, 605006 India.

Indian J Clin Biochem ; 34(3): 342-346, 2019 Jul.

Article em En | MEDLINE | ID: mdl-31391726

Palavras-chave

Adiponectin; Diabetes mellitus; Irisin; Nephropathy; Visfatin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google